KLRS
Kalaris Therapeutics, Inc.
2.60$
-3.8%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 88.6% | 100.0% | 98.2% | 99.2% | 87.2% | 100.0% | 99.1% | 98.7% | 96.3% | 97.6% | 89.3% | 96.4% | |
| 38.5% | 95.1% | 59.7% | 80.0% | 77.7% | 99.8% | 97.9% | 95.2% | 52.2% | 80.5% | 31.4% | 43.4% | |
| 85.9% | 95.1% | 97.5% | 99.0% | 77.7% | 99.8% | 97.9% | 95.2% | 94.9% | 96.9% | 88.5% | 94.0% | |
| 0.1% | – | 0.1% | 0.1% | – | – | – | – | – | – | – | – | |
| 21.3% | 1,450.6% | 16.4% | 8.2% | 3,731.9% | 4.4% | 38.0% | 42.8% | 48.4% | 35.3% | 37.6% | 42.1% | |
| 13.3% | 118.3% | 5.3% | 1.8% | 559.4% | 4.4% | 6.9% | 8.2% | 7.5% | 8.0% | 7.4% | 8.8% | |
| 5.2% | – | 1.6% | 0.5% | 376.0% | – | – | – | 0.5% | 0.3% | 0.3% | 0.3% | |
| 1.6% | 70.9% | 0.5% | 0.1% | 90.5% | 0.2% | 2.3% | 4.0% | 0.6% | 1.1% | 0.8% | 1.1% | |
| 78.7% | -1,350.6% | 83.6% | 91.8% | -3,631.9% | 95.6% | 62.0% | 57.2% | 51.6% | 64.7% | 62.4% | 57.9% | |
| -240.2% | -1,422.0% | -476.3% | -528.7% | -3,841.3% | -603.1% | -123.0% | -148.8% | -184.8% | -131.4% | -155.6% | -183.2% | |
| 2.0% | 148.7% | 3.5% | 3.8% | 202.4% | 4.2% | 3.9% | 20.1% | 23.0% | 18.8% | 21.6% | 23.9% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.